Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?

I love the smell of a potentially great micro-cap stock in the morning. And when that potential gem is cash rich, is advancing a late-stage pivotal trial, and has a consistent blessing from the FDA to perpetuate its late-stage trials, then that smell can transform into a fully baked and appetizing investment opportunity. For those … Read more